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PTEN is one of the most frequently mutated genes in
human cancer. It is known that PTEN has a wide
range of biological functions beyond tumor suppres-
sion. Here, we report that PTENa, an N-terminally
extended form of PTEN, functions in mitochondrial
metabolism. Translation of PTENa is initiated from
a CUG codon upstream of and in-frame with the
coding region of canonical PTEN. Eukaryotic transla-
tion initiation factor 2A (eIF2A) controls PTENa trans-
lation, which requires a CUG-centered palindromic
motif. We show that PTENa induces cytochrome c
oxidase activity and ATP production inmitochondria.
TALEN-mediated somatic deletion of PTENa impairs
mitochondrial respiratory chain function. PTENa
interacts with canonical PTEN to increase PINK1
protein levels and promote energy production. Our
studies demonstrate the importance of eIF2A-
mediated alternative translation for generation of
protein diversity in eukaryotic systems and provide
insights into the mechanism by which the PTEN
family is involved in multiple cellular processes.
INTRODUCTION
PTEN is a powerful tumor suppressor gene that is frequently
mutated in human cancer (Li et al., 1997; Steck et al., 1997;
Teng et al., 1997). Germline mutations of PTEN are associated
with tumor-susceptibility diseases, such as Cowden syndrome,
which is characterized by multiple hamartomas (Liaw et al.,
1997; Nelen et al., 1997). The role of PTEN as a potent tumor sup-
pressor has been demonstrated in many animal models, where
Pten deletion leads to development of various types of tumors
that mimic the spectrum of human cancers associated with
PTEN mutations (Di Cristofano et al., 1998; Podsypanina et al.,
1999; Stambolic et al., 2000). Pten loss also results in neurolog-
ical defects and metabolic disorders (Gasser, 2007; Stiles et al.,
2004; Stiles et al., 2006), suggesting that PTEN function is not836 Cell Metabolism 19, 836–848, May 6, 2014 ª2014 Elsevier Inc.limited to tumor suppression. PTEN is essential for embryonic
development as homozygous Pten deletion results in develop-
mental defects and embryonic lethality (Di Cristofano et al.,
1998; Podsypanina et al., 1999; Suzuki et al., 1998). These find-
ings all demonstrate the importance of PTEN in a diversity of bio-
logical processes including embryonic development, tissue
homeostasis, metabolism, and tumor suppression.
PTEN resides at the 10q23 locus and encodes a 403 amino
acid (aa) protein with an N-terminal phosphatase domain (Li
et al., 1997; Steck et al., 1997). The primary substrate of PTEN
phosphatase is phosphatidylinositol-3,4,5-triphosphate (PIP3),
a critical messenger for activation of the phosphoinositide-3-
kinase (PI3K)/AKT pathway (Maehama and Dixon, 1998). PTEN
dephosphorylates PIP3 at the plasma membrane and negatively
regulates PI3K/AKT-mediated cell survival and proliferation. In
the nucleus, PTEN maintains chromosomal integrity by stabiliz-
ing centromeres (Shen et al., 2007) and regulates cellular senes-
cence through APC-CDH1-mediated protein degradation (Song
et al., 2011). These nuclear PTEN functions are phosphatase in-
dependent and unrelated to the PI3K/AKT pathway (Shen et al.,
2007; Song et al., 2011). These findings indicate that PTEN func-
tions to control diverse fundamental biological processes, which
cannot be attributed merely to its phosphatase activity or to its
regulation of the PI3K/AKT pathway. It is therefore likely that
some severe observed consequences of PTEN dysfunction
result from loss of PTEN functions that are as yet unidentified.
Alternatively, unidentified forms of PTEN may exist that serve
in roles previously assumed to be functions of canonical PTEN.
PTEN is an evolutionarily conserved protein and has been
considered to be genetically unique without other isoforms. In
this study, we identified an alternate translation initiation at a
CUG site in the 50 untranslated region (50 UTR) of PTEN mRNA.
This CUG start codon generates a larger form of PTEN with an
elongated N-terminal region comprising an additional 173
(Homo sapiens) or 169 (Mus musculus) amino acids. We used
multiple approaches to demonstrate the existence of this new
form of PTEN, which we have designated PTENa. We show
that eIF2A-dependent CUG initiation is involved in PTENa syn-
thesis and that a CUG-centered palindromic sequence is
required for this process. PTENa is involved in the eukaryotic
electron transport process through induction of cytochrome c
oxidase activity in mitochondria, and disruption of PTENa
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a PTEN isoform of greater length and additional functions is pro-
duced by an alternative CUG translation initiation. Identification
of PTENa suggests reinterpretation of the importance of PTEN
in multiple fundamental cellular activities is warranted.
RESULTS
An Unknown 70 kDa Protein Shares an Expression
Pattern with PTEN and Is Recognized by PTEN
Antibodies
We have been interested in gene regulation in response to
cellular stresses, particularly oxidative stress (Liu et al., 2008;
Shen et al., 2006; Yin et al., 2003). During study of PTEN
response to oxidative stress, we found PTEN expression is
reduced following H2O2 treatment. We also noticed that a full-
length PTEN antibody reacted with an unidentified protein of
higher molecular weight (around 70 kDa; see Figure S1A avail-
able online), and this protein is expressed in a pattern identical
to that of PTEN. To determine whether differences in PTEN sta-
tusmay affect this larger PTEN-like protein, we examined a panel
of cancer cell lines and found that this 70 kDa protein is unde-
tectable in PTEN null cells (Figure S1B). A rabbit monoclonal
PTEN antibody against the PTEN C-terminal domain also recog-
nizes this PTEN-like protein (Figure S1B), indicating it likely
shares a C-terminal region with regular PTEN. These observa-
tions suggest a longer form of PTEN with the same C-terminal
regionmay exist. We designate this PTEN-like protein as PTENa.
PTENa Is Translationally Initiated from CUG513
Leucine-initiator tRNA-mediated translation starts at CUG co-
dons is a recently discovered mechanism of translation initiation
(Starck et al., 2012). We evaluated the 50 UTR of human PTEN
mRNA for alternative translation start sites and found a total of
six alternative CUG initiation codons in-frame with the canonical
AUG1032 start codon. Translation initiation from the first two
CUGs (highlighted in Figure 1A), CUG513 or CUG639, would
encode larger forms of PTEN comprising 576 or 534 amino acids,
respectively, with predicted molecular weights of 61–65 kDa. A
protein of this size may be expected to migrate at 70 kDa via
gel electrophoresis, which matches our observed PTENa band.
Closer assessment of theseCUGs reveals a16bpperfect palin-
dromic sequence centered on CUG513 (CCCGCUCCUGGAG
CGGG, underlined in red, Figure 1A), which may represent a
signaturemotif for translation initiation. Further phylogenetic anal-
ysis suggests that the PTENa start codon and the surrounding
palindromic sequence are evolutionary conserved (Figure 1B).
PTENCTG513 is 173aaupstreamof thecanonicalmethioninestart
codonATG1032. To determinewhether thisCUGcan initiate trans-
lation of this putative PTENa protein with upstream extension of
the open reading frame (ORF), we constructed a PTENa expres-
sion plasmid. As expected, the CTG513-initiated PTENa ORF is
translated into two distinct proteins with masses of 70 kDa
(PTENa) and 55 kDa (canonical PTEN) (Figure 1C). It is of note
that PTENa is expressed at lower abundance than PTEN. This
expression pattern is reversed when translation of PTENa is initi-
ated by the ATG start codon of N-terminal inserted FLAG tag, and
the 70+ kDa FLAG-PTENa band becomes dominant (Figure 1C).
This reversal indicates that CUG513 is a weaker initiator codonCthan AUG1032. These data suggest that PTENa can be translated
from a new ORF beginning with CUG codon(s) in the 50 UTR of
PTEN mRNA upstream of the canonical AUG start codon.
To confirm CUG-initiated translation of PTENa, we con-
structed a set of plasmids for expression of ATG1032-starting
PTEN and CTG513-starting PTENa, both with a C-terminal GFP
tag (Figures 1D and 1E). As both CTG513 and CTG639 can initiate
the translation of proteins of a similar size (70 kDa), we created
a mutation on each of these two CTGs separately to determine
which is necessary for PTENa expression. While PTEN-GFP
expression is not affected by mutation at either one of these
two sites, PTENa-GFP is differentially altered. Mutation at
CTG513 greatly diminishes PTENa, whereas mutation at
CTG639 has no such effect (Figures 1F and 1G). These results
indicate that CTG513, but not CTG639, is required for PTENa
expression and that CTG513 is likely the translation initiation
site for PTENa. These results are consistent with similar muta-
genesis assays obtained from other expression systems (Fig-
ure S1C). The mutation of CTG513 but not CTG639 into GGA or
CTA (coding the same amino acid, leucine, as CTG) abolishes
the PTENa band without decreasing expression of PTEN, while
mutation of both sites elicits a similar specific elimination of
PTENa (Figures S1D and S1E). Further mutagenesis analysis
suggests that switching ATG and CTG can reverse the domi-
nance hierarchy status of PTEN and PTENa. While mutation of
ATG1032 to ATA eliminates canonical PTEN (Figure S1E),
replacement of CTG513 with ATG and ATG1032 with GGA results
in elevation of PTENa and reduction of PTEN (Figure S1D). These
data collectively demonstrate that PTENa synthesis relies on an
alternative translation initiation at the CUG513 codon.
Mass Spectrometry Analysis Reveals the PTENa
Sequence
In order to validate the PTENa translation start site, we sought
direct evidence using mass spectrometry for peptide
sequencing. We first purified human PTENa with a C-terminal
His tag (Figure 2A) expressed in E. coli for mass spectrometry
(Figure 2B).Mascot reports reveal six peptide fragments covering
55.5% of the N-terminal region of PTENa (from CTG513 to
ATG1032, designated as aN; Figure 2B). In particular, the most
proximal N-terminal peptide (17 aa, MS/MS spectrum shown in
Figure 2C) ismapped near the first leucine initiator (CTG513), sug-
gesting that CTG513 is the initiation site for PTENa translation.
Regular LC-MS/MS captures the 17 aa peptide adjacent to the
PTENa N terminus, but not the 3 aa proximal end, LER. To
improve the chances of trapping this small fragment, we purified
a C-terminally His-tagged PTENa protein expressed in Sf9 insect
cells (Figures 2D and 2E) and utilized the TMPP-Ac-Osu deriva-
tization approach (Chen et al., 2007; Huang et al., 1999) for
MALDI-TOF/TOF MS and de novo sequencing. This resulted in
the identification of the first three N-terminal amino acids of
PTENa, LER (Figures 2F and 2G). The mass spectrum data
confirm that CUG513 is the PTENa translation initiation site.
Validation of the PTENa Gene Locus and Translation
Initiation Using a C-Terminal FLAG-Knockin Mouse
Model
Comparison of the 50 UTR of Homo sapiens PTEN and Mus
musculus Pten reveals 95% homology (Figure S2A), suggestingell Metabolism 19, 836–848, May 6, 2014 ª2014 Elsevier Inc. 837
Figure 1. Identification and Validation of PTENa
(A) Sequence of the 50 UTR region of Homo sapiens PTEN mRNA. Two potential CUG sites (red and pink) as well as the normal ATG start site (green) are
highlighted.
(B) The 50 UTR of PTEN containing the 16 bp CUG-centered palindromic motif is evolutionarily conserved. Phylogenetic analysis of the 50 UTR of PTEN mRNA in
bonobo (Pan paniscus), wild boar (Sus scrofa), horse (Equus caballus), cattle (Bos taurus), killer whale (Orcinus orca), and mouse (Mus musculus). The 16 bp
palindromic sequence is highlighted in a green box, and the ATG start codon of canonical PTEN is in a blue box.
(C) PTEN cds with a CUG513-starting 50 UTR region (PTENa) was constructed under a CMV promoter and expressed with and without a N-terminal FLAG tag.
Human HEK293T cells were transfected with indicated expression plasmids, followed by western blotting analysis using a PTENmonoclonal antibody against its
C-terminal region.
(D) A different set of constructs of PTEN and PTENawith aC-terminal GFP tag, in which one of the two possible CTG sites (CTG513 or CTG639) wasmutated to CTA
or GGA.
(E–G) Mutation of CTG513 but not CTG639 eliminates the expression of PTENa. C-terminal GFP-tagged PTENa expression plasmids with and without CTG513 >
CTA or CTG513 > GGA mutation(s) were introduced in human HCT116 colon cancer cells, followed by detection of GFP-PTENa variants. (E) The expression of
GFP-tagged PTENor PTENawas confirmed bywestern blotting using aGFP antibody. (F andG)Mutation of CTG513 but not CTG639 into CTA or GGA results in the
disappearance of PTENa. PTENa-G and PTEN-G, PTENa, or PTEN with a C-terminal GFP tag.
See also Figure S1.
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apply in mice. In order to further identify the gene locus of Ptena
and its translation initiation site, we generated a FLAG-knockin
mouse model (PtenFLAG), in which the C terminus of the Pten
genewas targeted for insertion of a FLAG-coding sequence (Fig-
ures 2H and S2B). To verify the existence of Ptena at the Pten
gene locus, tissue samples were extracted from heterozygous
PtenFLAG mice and wild-type control mice for FLAG pull-down.
Theoretically, a FLAG pull-down procedure will reveal all poten-
tial Pten isoforms with the same FLAG-tagged C terminus but
varying lengths of N termini. Two distinct protein bands are
detectable in the FLAG elute from PtenFLAG tissues, with molec-
ular masses of 70 and 55 kDa (Figure S2C). No Pten is detected
in wild-type tissues (Figures 2I and S2C). The two forms of FLAG-
tagged Pten protein found in PtenFLAG knockin mice are of
molecular masses similar to the two endogenous Pten forms
previously observed in MEFs (Figure S2C). The 70 kDa band in
MEFs was recognized by an antibody raised against the
PTENa-specific aN region (Figures S2D and S2E). The existence
of in vivo Ptena with an N-terminally extended aN region was
further confirmed by mass spectrometric analysis of a FLAG-pu-
rified 70+ kDa band from PtenFLAG tissues (Figure 2J). One of the
six identified Ptena peptides (167–175, LPDmTAIIK, underlined)
spans the border of aN and PTEN. The evidence that PtenFLAG
knockin tissues express C-terminal FLAG-tagged Ptena sug-
gests that Ptena and Pten can be translated in vivo from the
same mRNA at the same gene locus. The PtenFLAG knockin an-
imal model demonstrates the natural occurrence of alternative
initiation that results in the translation of Ptena.
Critical Role of eIF2A-Mediated CUG Initiation in PTENa
Synthesis
The eIF2A-dependent mechanism plays an important role in
initiation at CUG start codons, and structurally distinct com-
pounds can differentially inhibit protein synthesis initiated by
AUG or CUG start codons. For example, acriflavine inhibits
CUG initiation, whereas aurin trycarboxylic acid (ATA) inhibits
initiation at the AUG start codon but enhances CUG initiation
(Starck et al., 2012). We examined expression levels of PTENa
in response to these chemical inhibitors and found that ATA, a
known enhancer of CUG initiation, induces PTENa expression
(Figure 3A). On the other hand, acriflavine reduces PTENa
expression in a dose-dependent manner without affecting
PTEN expression (Figure 3B). Overexpression of eIF2A signifi-
cantly increases PTENa expression (Figure 3C), whereas
PTENa is downregulated in eIF2A knockdown cells (Figure 3D).
These data indicate that PTENa is synthesized through an
eIF2A-mediated translation CUG initiation mechanism.
As noted earlier, CUG513 is embedded in a 16 bp palindromic
motif (Figure 1A, underlined sequence). Many previously
reported genes with a CUG start codon have similar CUG-
centered palindromic sequences (Figure S3A). In order to
determine whether this motif influences translation initiation at
CUG513, we constructed PTENa mutants to disrupt the palin-
drome (Figure 3E) and examined PTENa expression. Mutation
of the nucleotide triplets immediately upstream or downstream
of CTG513 (CTC510 > TAG or TAT, or CAG516 > TCT) greatly
reduces PTENa expression (Figures 3F and S3B). At the same
time, disruption of this palindromic motif by direct mutation ofCCUG513 itself to either CUA or AAA leads to a greater reduction
of PTENa (Figure 3F). Interestingly, the alteration CTC510 > TAT
at the 50 end of the CUG start codon leads to about 50%
decrease in levels of PTENa, while GAG516 > TCT, which lies
exactly on the opposite side of the palindrome, decreases
PTENa to a mere 5%–10%, implying that the positions at the
30 end are more important than those at the 50 end. These data
suggest that the palindromic sequence surrounding CUG513
may serve as a signal for CUG initiation site recognition, in a
manner similar to the Kozak sequence for AUG initiation.
Localization of PTENa in Mitochondria
To examine the subcellular localization of PTENa and compare it
with that of PTEN, we first employed a protease protection
assay. Cells transfected with N-terminal or C-terminal GFP-
tagged PTENa or PTEN were subjected to consecutive diges-
tion with digitonin (cytoplasmic membrane permeabilization)
and trypsin (removal of cytosolic exposed terminus of organ-
elle-associated protein). To make sure only one isoform is ex-
pressed, we created an ATG1032 > ATA mutation in GFP-tagged
PTENa. As shown in Figure 4A, PTENa exhibits a signal pattern
distinctly different from PTEN, with and without protease diges-
tion. Prior to digitonin treatment, PTEN is ubiquitously distrib-
uted in both the cytoplasm and the nucleus, but PTENa displays
predominantly cytoplasmic localization. Digitonin treatment
eliminates the majority of the cytoplasmic PTEN signal but
PTENa signals are partially retained, suggesting that PTENa
can be cytosolic or associated with cytoplasmic organelles,
whereas PTEN is mainly cytosolic. Further trypsin digestion re-
moves all PTEN signals but does not affect digitonin-retained
PTENa signals, regardless of the GFP position. It appears that
PTENa is predominantly localized in the cytoplasm and may
have multiple intracellular forms, including a cytosolic form (pro-
tease sensitive) and an organelle-associated form (protease
insensitive). We next used MitoTracker to label mitochondria
and evaluate potential colocalization of C-terminal GFP-tagged
PTENa or PTENwith mitochondria. We observed substantial co-
localization of PTENa with mitochondria, whereas mitochondrial
colocalization is less prominent for PTEN (Figure 4B). To deter-
mine whether endogenous PTENa can be detected in mitochon-
dria, we performed a fractionation procedure to separate the
mitochondria from the cytoplasm. PTENa is found in the mito-
chondrial fraction of Pten+/+ MEFs, whereas canonical PTEN is
found primarily in the cytoplasmic fraction (Figure 4C). Further
evaluation of submitochondrial localization suggests that
PTENa is preferentially associated with the mitochondrial inner
membrane and is less abundant in the outer membrane (Fig-
ure 4D). These data suggest that the N-terminal extended
region may endow PTENa with distinct cellular localization and
function and that PTENa may be involved in mitochondrial
function.
Role of PTENa in Mitochondrial Respiratory Chain
Function
In order to determine whether PTENa is involved inmitochondrial
oxidative phosphorylation (OXPHOS), we measured the enzy-
matic activities of different OXPHOS complexes. We found that
although the NAD/NADH ratio is reduced in Pten null MEFs as
compared to wild-type cells, neither complex I nor II isell Metabolism 19, 836–848, May 6, 2014 ª2014 Elsevier Inc. 839
Figure 2. The Translation Initiation Codon of PTENa Is Identified by MALDI-TOF Mass Spectrometry and Terminal Analysis with De Novo
Sequencing
(A) A pET28a plasmid containing PTENa with a C-terminal His-tag used for in vitro purification and mass spectrometry sequencing.
(B) His-selected affinity purification of PTENa. Bacteria-expressed His-PTENawas purified using nickel affinity chromatography. Combined fractions containing
the slow migrating PTEN band (fractions 6–10) confirmed by PTEN immunoblotting (data not shown) were separated with SDS-PAGE. Mass spectrometry
analysis of a purified 70 kDa band (in red box) revealed six pieces of peptide that match the 50 UTR region of PTEN, including a peptide near the CTG513-
leucine site.
(C) The MS/MS spectrum of the peptide (GGEAAAAAAAAAAAPGR) that matches the N-terminal sequence of PTENa.
(D) A pFastBac1 plasmid containing PTENawith a C-terminal His-tag used for in vitro purification andmass spectrometry sequencing. The PTEN ATG start codon
was mutated to ATA to avoid PTEN copurification with PTENa.
(legend continued on next page)
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Figure 3. PTENa Is Synthesized through an
eIF2A-Mediated CUG Initiation Mechanism,
and a Palindromic Sequence Is Essential for
PTENa Expression
(A) Induction of PTENa by aurin tricarboxylic acid
(ATA) in a time-dependent manner. HeLa cells
were treated with ATA (80 mM) for various periods
of time, and the expression of PTENa as well as
PTEN was examined by western blot.
(B) Dose-dependent inhibition of PTENa expres-
sion by acriflavin. HeLa cells were treated with
different doses of acriflavin for 4 hr prior to
immunoblotting for evaluation of PTENa expres-
sion. Expression levels of PTEN and GAPDH were
included as controls.
(C) eIF2A alters the ratio of PTENa versus PTEN
by upregulating PTENa and downregulating
PTEN. FLAG-tagged eIF2A was overexpressed
in HEK293T cells prior to western evaluation of
PTENa and PTEN. eIF2A expression was verified
by probing the same blot with anti-FLAG antibody.
GAPDH was used as a loading control.
(D) Reduction of PTENa in response to knockdown
of eIF2A. HeLa cells were infected with lentivirus
expressing eIF2A shRNA or scramble shRNA. Cell
lysates were analyzed by western blotting with
antibodies against eIF2A, PTEN (m), and GAPDH.
(E) CTG513-centered palindromic sequence and
disruption of the palindrome by mutagenesis.
(F) Abolition of PTENa by palindrome disruption.
Mutations were made at CTC510, the triplet
immediately before the CTG513 start codon, or at
CTG513 itself as indicated prior to western analysis
of PTENa expression.
See also Figure S3.
Cell Metabolism
PTENa in Metabolismsignificantly affected (Figures S4A–S4C). Similar results were
observed in cells with somatic PTENa deletion (Figures S4D–
S4F). Among different OXPHOS complexes, the complex IV
(cytochrome c oxidase, COX) is found to be the primary target
of PTENa. Cytochrome c oxidation represents a critical feature
of mitochondrial function in coupling electron transport and
oxidative phosphorylation (Coenen et al., 2001). As alternative
CUG translation initiation induced by ATA can elevate endoge-
nous PTENa (Figures 3A), we sought to determine whether
induction of endogenous PTENa could enhance mitochondrial
respirasome function. ATA-treated cells containing wild-type
PTEN express a higher level of PTENa (Figures 5A and S5A)
and consequently show an increase in COX activity (Figures(E) Purification of SF9-expressed PTENa with a C-terminal His-tag (band in red
sequencing.
(F) Tandem spectrum of m/z 989.3727 in TMPP-Ac derivatized PTENa.
(G) De novo analysis of m/z 989.35 showing the first amino acids of PTENa, leuc
(H) Generation of Pten C-terminal FLAG knockin mice for verification of the Pten
(I) Verification of expression of FLAG-tagged PTEN and PTENa in Pten-FLAG k
wild-type mice were lysed for immunoblotting with anti-FLAG antibody.
(J) Protein lysates of Pten-FLAG knockin liver tissues or control tissues were su
PTENa-specific antibody. The bound proteins were separated with SDS-PAGE,
peptides were identified in Pten-FLAG knockin tissues that match the N-termina
See also Figure S2.
C5B and S5B). These data indicate that PTENa can stimulate
mitochondrial COX activity even in the presence of a substantial
level of canonical PTEN.
To determine how PTENa alters mitochondrial function in the
presence or absence of canonical PTEN, we transfected FLAG-
tagged PTENa as well as canonical PTEN into Pten/ MEFs
for analysis of COX activity. While PTEN is expressed primarily
in the cytoplasm, ectopic PTENa is found largely in the mito-
chondria (Figure 5C). Interestingly, the basal COX activity in
Pten/ MEFs is only 25% of that in Pten+/+ cells (Figure 5D),
suggesting that PTEN or PTENa is essential in mitochondrial
oxidative metabolism. As deletion of PTEN simultaneously
disrupts PTENa expression, it is important to clarify which ofbox) for MALDI-TOF-TOF MS and TMPP-Ac-OSu derivatization for de novo
ine-glutamic acid-arginine (LER).
a gene locus.
nockin mice. Liver and lung tissues from Pten-FLAG knockin mice or control
bjected to sequential immunoprecipitation with anti-FLAG M2 agarose and a
and gel slices at around 70 kDa were analyzed by mass spectrometry. Four
lly extended region of PTENa, aN.
ell Metabolism 19, 836–848, May 6, 2014 ª2014 Elsevier Inc. 841
Figure 4. PTENa Is Localized Predomi-
nantly in the Cytoplasm and Mitochondria
(A) Pten/ MEFs transfected with N-terminal or
C-terminal GFP-tagged PTEN or PTENa were
subjected to protease protection assay, confirm-
ing the difference in subcellular distribution patters
of PTENa and PTEN.
(B) Subcellular localization of C-terminal GFP-
tagged PTENa (with an ATG > ATA mutation) and
PTEN shown by confocal fluorescence micro-
scopy. MitoTracker was used to indicate mito-
chondria. Overlay, merged images of GFP and
MitoTracker.
(C) Cell fractionation was performed to isolate
mitochondria in Pten+/+ and Pten/MEFs prior to
immunoblotting analysis of Ptena and Pten
expression. W,whole-cell lysate;M,mitochondria;
C, cytoplasm. Cytochrome c and a-tubulin were
used as mitochondrial and cytoplasmic markers.
(D) Mitochondria isolated frommouse brain cortex
were subjected to subfractionation of mitochon-
dria prior to evaluation of Ptena by immunoblot-
ting. Tom40 and Cox1 were used as markers for
the mitochondrial outer membrane and inner
membrane, respectively. Cytochrome c is a dy-
namic component of mitochondria and can be
found in both the inner membrane and intermem-
brane space.
See also Figures S4–S7.
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tion. Ectopic expression of PTENa in Pten null cells is able to
fully rescue COX activity, whereas PTEN can also induce
COX activity but to a lesser extent (Figures 5D and S5E). These
data suggest that although both PTEN and PTENa are capable
of maintaining COX activity, the preferential mitochondrial
localization of PTENa may confer an advantage in energy
metabolism.
Human MCF-7 breast cancer cells express only a trivial level
of PTENa but a high level of canonical PTEN (Figure S2E),
which makes MCF-7 cells a model for functional study of
PTENa in the presence of canonical PTEN. We found that
COX activity is increased by overexpression of PTENa in the
presence of a substantial level of canonical PTEN (Figures
S5C and S5D). Similarly, COX activity is induced by ectopic
PTENa expression in human PC-3 prostate cancer cells null842 Cell Metabolism 19, 836–848, May 6, 2014 ª2014 Elsevier Inc.for PTEN, suggesting that PTENa can
induce COX activity even in the absence
of canonical PTEN. These data support
the concept that PTENa plays an impor-
tant role in regulation of mitochondrial
function.
To further assess the relationship of
PTENa with mitochondrial function, we
examined PTENa localization and COX
activity in various mouse tissues. Despite
enrichment of PTENa in mitochondria
similar to human cells, PTENa seems to
be preferentially expressed in energy-
consuming tissues such as skeletal and
cardiac muscle (Figure 5E). More inter-estingly, expression levels of PTENa in different tissues corre-
spond to levels of COX activity (Figure 5F), further highlighting
the involvement of PTENa in mitochondrial respiratory chain
function.
Like canonical PTEN, PTENa contains an intact phosphatase
domain. To determine whether PTENa phosphatase activity is
involved in mitochondrial function, we constructed a phospha-
tase-deficient PTENa mutant (C297S). This mutation signifi-
cantly decreases PTENa-induced COX activity (Figure S5F),
suggesting PTENa phosphatase function is involved in regula-
tion of COX activity. Similar results were also observed with
PTEN and its C124Smutant (Figure S5F). PTENa is preferentially
localized in the inner membrane of mitochondria (Figure 4),
where multisubunit COX accumulates. Interestingly, in vivo
coimmunoprecipitation reveals that PTENa may physically
associate with COX1 (Figure S5G). Phosphorylation of COX
Figure 5. PTENa Regulates Cytochrome c
Oxidase Activity
(A) Pten+/+ and Pten/ MEFs were treated with
ATA (100 mM, 24 hr) and examined for expression
levels of PTEN and PTENa.
(B) Mitochondrial fractions were extracted from
Pten+/+ and Pten/ MEFs treated with ATA as in
(A) for analysis of cytochrome c oxidatase (COX)
activity. Data are presented as mean ± SEM of
three independent experiments and analyzed with
the paired t test. *p < 0.05; **p < 0.01.
(C) Pten+/+ and Pten/ MEFs with and without
ectopic expression of FLAG-tagged PTEN or
PTENa were subjected to a cell fractionation
procedure for isolation of mitochondria, followed
by immunoblot analysis of PTEN/PTENa expres-
sion. Cytochrome c and a-tubulin were used as
mitochondrial and cytoplasmic markers. M, mito-
chondria; C, cytoplasm.
(D)Mitochondria fromPten+/+MEFsaswell as from
Pten/ MEFs containing ectopic PTEN or PTENa
were analyzed forCOXactivity. Data are presented
as mean ± SEM of three independent experiments
and analyzed by paired t test. **p < 0.01.
(E) Various mouse tissues were subjected to
mitochondria/cytoplasm fractionation, followed
by western analysis of PTENa expression. PTEN
expression is also shown for comparison. GAPDH
and cytochrome c were used as cytoplasmic and
mitochondrial markers.
(F) Mitochondria were extracted from various
mouse tissues as indicated for analysis of COX
activity.
See also Figures S4–S7.
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phosphorylated COX1 at Tyr304 loses its enzymatic activity
(Lee et al., 2005). These earlier studies, together with our data,
imply that PTENa may regulate COX activity through mainte-
nance of COX hypophosphorylation.
PTENaMaintains Mitochondrial Structure and Function
To evaluate the importance of PTENa, we employed transcrip-
tion activator-like effector nucleases (TALEN) technology (Boch
et al., 2009; Moscou and Bogdanove, 2009) to induce somatic
PTENa knockout (Figure 6A). TALEN-mediated gene targeting
eliminatedPTENawithout affectingPTENexpression (Figure 6B).
Electron microscopy reveals an increased number of abnormal
mitochondria with altered shape and size in PTENa/ cells,
manifested by much smaller mitochondria with irregular shape
and dense matrix, as well as enlarged luminal vesicles (Fig-
ure 6C). We also examined mitochondrial membrane potential
by staining PTENa knockout cells with JC-1 membrane-perme-
able dye. As shown in Figure 6D, JC-1 shows red fluorescent
J-aggregates in wild-type cells, indicating the membrane poten-
tial is hyperpolarized. In contrast, these red J-aggregates are
lost in PTENa knockout cells, and diffuse green fluorescence
becomes prominent instead, indicating mitochondrial depolari-Cell Metabolism 19, 836zation. These results suggest that PTENa
depletion reduces mitochondrial mem-
brane potential and increases perme-ability. Mitochondrial damage may interfere with energy meta-
bolism, and indeed, we found a significant reduction of
mitochondrial COX activity and ATP production in response to
TALEN-mediated PTENa knockout (Figures 6E and 6F). These
results demonstrate that PTENa is necessary for the mainte-
nance of mitochondrial structure and function. It is of interest
to note that in the presence of canonical PTEN, depletion of
PTENa results in an 30% reduction of COX activity (Figure 6E),
which is less dramatic than deletion of both Pten and Ptena in
Pten/ MEFs (>75% reduction; Figure 5D). These observations
suggest that PTEN plays a role in attenuating the COX defect
associated with the lack of PTENa and that these two isoforms
may play a synergistic role in COX regulation.
To determine whether PTEN distribution in mitochondria may
be altered by PTENa status, we compared PTEN expression and
localization in the presence and absence of PTENa and found
that TALEN-induced PTENa depletion results in reduced mito-
chondrial expression of PTEN (Figure S6A). We next employed
confocal microscopy with MitoTracker as a mitochondrial
marker and cotransfected Pten-null cells with S-tagged PTEN
with or without GFP-tagged PTENa. As shown in Figure S6B,
more overlapping PTEN signals were found with MitoTracker in
the presence of PTENa. These data suggest that PTEN may be–848, May 6, 2014 ª2014 Elsevier Inc. 843
Figure 6. Somatic Knockout of PTENa
Impairs Mitochondrial Structure and
Function
(A) Somatic knockout of PTENa with the TALEN
technique. Upper panel, schematic strategy of
PTENa TALEN knockout. Lower panel, sequence
of PTENa CDS in exon 1. TALEN-targeted left and
right arms are underlined and highlighted in
orange. CTG513 and ATG1032 are highlighted in red
and green, respectively.
(B) Western blot confirming elimination of PTENa.
(C) Marked mitochondrial morphological alter-
ations in PTENa/ HeLa cells shown by electron
microscopy. Arrowheads indicate smaller
condensed mitochondria. The arrow points to a
mitochondrion with expanded vesicles.
(D) JC-1 staining showing loss of red-J-aggregate
fluorescence in PTENa/ cells (right) as com-
pared with PTENa+/+ cells (left).
(E) Impaired COX activity in PTENa/ cells.
Mitochondria were extracted from PTENa+/+ and
PTENa/ cells for analysis of COX activity.
(F) PTENa knockout reduces ATP production.
Data are presented as mean ± SD of three repli-
cates and analyzed by paired t test. **p < 0.01.
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the regulators of mitochondrial energy metabolism.
PTENa and PTEN Form a Complex and Collaborate to
Increase PINK1 Protein Levels and ATP Production
Although PTENa and PTEN exhibit distinct patterns of subcellu-
lar localization (Figure 4), both can induce COX activity (Fig-
ure 5D). We therefore hypothesized that PTENa collaborates
with PTEN in mitochondrial bioenergetics through formation of
a PTEN-PTENa complex. We first introduced PTENa and
PTEN with different tags into 293T cells. Using S-tagged PTEN
as bait, we found that FLAG-tagged PTENa exists in the S-puri-
fied protein complex (Figure 7A), indicating that PTEN can
interact with PTENa. In vivo coimmunoprecipitation assay
further confirmed the interaction between endogenous PTENa
and PTEN (Figure 7B).
In order to determine how PTEN and PTENa coordinate in
energy metabolism, we transfected Pten/ MEFs with PTEN
or PTENa individually and in combination (Figure S7A). The high-844 Cell Metabolism 19, 836–848, May 6, 2014 ª2014 Elsevier Inc.est COX activity and ATP production
were found in cells expressing both
PTEN and PTENa (Figures S7B and
S7C). No statistical significance was
found in PTENa only versus PTENa+
PTEN transfection, but this may due to
the fact PTEN transfection is less efficient
when cotransfected with PTENa. These
data suggest that PTENa and PTEN
collaborate to regulate COX activity and
ATP production.
PTEN-induced kinase 1 (PINK1) is a
mitochondria-targeted serine/threonine
kinase that plays an important role
in protection of mitochondrial function(Narendra et al., 2012; Valente et al., 2004). We found a reduced
level of PINK1 expression in cells lacking PTENa (Figure 7C).
Interestingly, both PTENa and PTEN can increase protein levels
of PINK1 in Pten null cells (Figure 7D), and PTENa seems to play
a more prominent role. To translate these molecular events into
readout of cellular energy, we measured ATP production in cells
with ectopic PTENa, PTEN, and PINK1 individually and in com-
bination. Each individual protein can significantly promote ATP
production (Figure 7E). It is important to note that PTENa can
significantly augment the ability of PTEN or PINK1 to induce
ATP production, whereas addition of PTEN or PINK1 does not
significantly increase the effect of PTENa. These results suggest
that PTENa plays a driving role in regulating PTEN and PINK1 in
energy production.
DISCUSSION
In eukaryotes, protein translation of mRNA is typically initiated
at AUG codons, and the efficiency of initiation depends on the
Figure 7. PTENa and PTEN Form a Complex and Collaborate in Energy Metabolism
(A) S-HA-tagged PTEN and FLAG-HA-tagged PTENa were transfected into 293T cells prior to S protein pull-down (S-PD). FLAG or HA immunoblotting was
performed to detect PTEN-associated PTENa.
(B) In vivo binding of PTENa with PTEN. Endogenous PTENa was immunoprecipited using anti-aN antibody from mouse brain tissues for immunoblotting
of PTEN.
(C) Evaluation of PINK1 expression in PTENa depleted cells by western blotting.
(D) PINK1 expression was assessed in Pten/ MEFs transfected with PTEN, PTENa, or PTEN+PTENa.
(E) Pten/MEFs transfected individually or in different combinations with PTEN, PTENa, and PINK1, followed by analysis of ATP production. Data are presented
asmean ± SD. Labeling above each column indicates statistical significance of comparison with the control column. n.s., not significant, p > 0.05; *p < 0.05; **p <
0.01; ***p < 0.001.
(F) A graphic model of PTENa translation and its function in mitochrondrial energy metabolism. PTENa is synthesized through an eIF2A- and palindrome-
dependent CUG initiation mechanism. PTENa forms a complex with canonical PTEN, and these molecules collaborate in mitochondrial bioenergetics through
regulation of cytochrome c oxidase activity and ATP production.
See also Figures S6 and S7.
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(Kozak, 1999). There is growing evidence, including the findings
in this study, that shows translation initiation also occurs at non-
AUG codons (Gerashchenko et al., 2010; Hann et al., 1988;
Malarkannan et al., 1999; Ne´meth et al., 2007), which enhances
genome coding capacity and protein diversity. While CUG
appears to be the most common non-AUG initiation codon (Pea-
body, 1989; Wegrzyn et al., 2008), the mechanism underlyingCCUG initiation was unknown until recently, when it was shown
that CUG can be decoded by a specific leucyl-tRNA to initiate
alternative translation in an eIF2A-dependent pathway (Starck
et al., 2012). We demonstrate that such a mechanism is respon-
sible for the synthesis of PTENa. Bioinformatics analysis pre-
dicted a Kozak-like codon context and mRNA secondary
structural features for translation initiation at CUG codons
(Wegrzyn et al., 2008). In this study, we found a perfectell Metabolism 19, 836–848, May 6, 2014 ª2014 Elsevier Inc. 845
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Because disruption of this palindrome abolishes PTENa syn-
thesis, the palindrome sequence surrounding CUG may there-
fore represent a signature motif for alternative Leu-tRNA
initiation (see Figure S7F). PTENa is the first nonantigenic protein
that is synthesized through the Leu-tRNA initiation mechanism.
The identification of PTENa advances our understanding of pro-
tein diversity mediated by alternative translation initiation.
Recently, Hopkins et al. reported a longer form of PTEN
(PTEN-Long) that is secreted into adjacent cells and antagonizes
PI3K/AKT signaling (Hopkins et al., 2013). This study significantly
expands the functional scope of the PTEN family from intracel-
lular to extracellular. Although PTEN-Long was predicted to
have the same translation initiation codon as PTENa based on
sequence inspection, there was no peptide sequence provided
or verified by mass spectrometry in the report by Hopkins et al.
Based on our analysis, the CUG initiation mechanism may
encode several larger forms of PTEN. It is therefore important
that any longer putative PTEN isoforms be verified by mass
spectrometry. As multiple forms of PTENmay exist, we consider
it to bemost prudent to designate PTEN isoforms as a sequential
series, such as a, b, or g.
Our data demonstrate that PTENa is involved in the electron
transfer reaction and ATP production, likely through regulation
of COX activity, the rate-limiting enzyme in the respiratory chain.
Multiple mechanisms may be involved in PTENa regulation of
COX activity. PTENa can promote COX activity by increasing
the protein level of PINK1 as well as through physical association
with COX1 and modulation of its phosphorylation status.
Based on our observations, canonical PTEN can also promote
COX activity and ATP production, although to a lesser extent as
comparedwithPTENa.Other recent reports have also suggested
that PTEN may be involved in metabolic regulation (Fang et al.,
2010; Garcia-Cao et al., 2012). In particular, data from super-
PTENmice suggest that additional copies ofPTEN increasemito-
chondrial oxidativephosphorylation andATPproduction (Garcia-
Cao et al., 2012). As BAC-mediated transgenesis delivers the
entire Pten locus containing the coding sequence of Ptena into
the genome of the super-PTEN mice, the observed phenotype
with this metabolic shift may result from additional copies of
PTENa, or from a combination of PTEN and PTENa. PTENa
shares the majority of its sequence with PTEN, and viewed in
retrospect, current Pten knockout mouse strains are therefore
essentially models of Pten and Ptena double knockout. Thus,
phenotypic deficiencies in these double knockout mice may be
partially attributed to loss of Ptena or its aN region. By utilizing
TALEN-mediated somatic PTENa knockout, our study demon-
strates the essential role of PTENa inmitochondrial bioenergetics
and coordinated regulation of PINK1 with canonical PTEN.
In this study, we identify PTENa as a PTEN isoform important
for mitochondrial energy metabolism. Recognition of PTENa
helps understand the complexity of PTEN function and sheds
light on what have previously been viewed as baffling pheno-
mena in animal models. This study provides a model for
PTENa translation through the eIF2A-mediated CUG translation
initiation mechanism, and shows how the PTEN family may
participate in multiple distinct cellular functions. Our data
demonstrate that mammalian cells can utilize the novel eIF2A/
CUG/Leu-tRNA initiation mechanism to generate isoforms from846 Cell Metabolism 19, 836–848, May 6, 2014 ª2014 Elsevier Inc.what was originally thought to be a unique gene. These findings
also raise the possibility that the PTEN family may have addi-
tional as-yet-unidentified members. Identification of new PTEN
isoforms will advance our understanding of the diversity of
PTEN functions in physiological and pathological processes.
EXPERIMENTAL PROCEDURES
Plasmids and Antibodies
To construct the PTENa and PTEN expression plasmids, full-length PTEN
cDNAs with or without an additional 50 UTR region corresponding to
CTG513-TGA2243 or ATG1032-TGA2243 of PTEN mRNA were amplified by PCR
from HeLa cDNA and inserted with or without an N-terminal FLAG-tag into a
pcDNA3.1 vector. The PTENa (CTG513-TGA2243), and PTEN coding sequences
(ATG1032-TGA2243) were subcloned either into pET28a(+) for expression in
bacteria or into pEGFP-N1 or pEZYMyc vector with a C-terminal GFP or
Myc tag for expression in mammalian cells. Different CTG or ATG mutants
were created using a site-directed mutagenesis kit (Invitrogen). The expres-
sion plasmid for eIF2A was constructed by cloning full-length eIF2A cDNA
into a mammalian expression vector with an N-terminal tag.
To prepare PTENa-specific antibodies, the DNA sequence corresponding to
the full-length aN region of PTENa (CTG513-GAC1031) was subcloned into the
pET-28a vector, and aN protein was purified by His affinity chromatography
for antibody production in rabbits (SDIX).
Mice
A knockin mouse strain was generated in this study by knocking a FLAG tag
into the Pten C terminus for identification of any potential alternative earlier
translation initiations. For details, see Supplemental Experimental Procedures.
Mass Spectrometry and De Novo Sequencing
Tissue protein lysates from PtenFLAG knockin mice were subjected to FLAG
pull-down followed by an additional round of immunoprecipitation using a
PTENa-specific antibody. Corresponding tissues from wild-type mice
(Pten+/+) were simultaneously processed as control. Gel slices excised from
Pten+/+ and PtenFLAG/+ samples around 70 kDa were analyzed by mass spec-
trometry for in vivo identification of Ptena. For in vitro verification and de novo
sequencing, see Supplemental Experimental Procedures.
TALEN-Mediated Somatic PTENa Knockout
To specifically knockout PTENa, a TALEN binding pair was chose from PTENa
CDS in the first exon between CTG513 and ATG1032. For details, see
Supplemental Experimental Procedures.
Subcellular Fractionation and Mitochondrial Subfractionation
A Millipore mitochondria/cytosol fractionation kit was used for extraction of
mitochondria and nuclear/cytoplasm extraction reagents were used for sepa-
ration of nuclei from cytoplasm. For subfractionation of mitochondria, see
Supplemental Experimental Procedures.
Immunofluoresence and Confocal Microscopy
C-terminal GFP-tagged PTEN or PTENa was subjected to confocal micro-
scopy for evaluation of their subcellular localization, and MitoTracker
(Invitrogen) was used to indicate mitochondria.
Protease Protection Assay
A GFP tag was added to the N terminus or C terminus of PTEN and PTENa
using pAcGFP and pEGFP plasmids for protease protection assay. The
ATG1032 start codon of PTEN in the PTENa expression vector was mutated
to ATA to avoid simultaneous PTEN expression. For details, see Supplemental
Experimental Procedures.
Mitochondrial Respiratory Chain Function
Different mitochondrial respiratory chain complexes were analyzed indepen-
dently with isolated mitochondria. A COX assay kit and an ATP bioluminescent
assay kit (Sigma) were used for measurement of COX activity and ATP
Cell Metabolism
PTENa in Metabolismproduction. A JC-1 staining kit (Biotium) was used for measurement of mito-
chondrial membrane potential.
Statistical Analysis
Data from three independent experiments were analyzed by unpaired t test,
and error bars represent standard error of the mean (SEM), unless otherwise
stated. The statistical significances between data sets were expressed as
p values, and p < 0.05 was considered statistically different.
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